JPRN-jRCT1080222313未知Unknown
ECARD Combination Tablets LD&HD special drug use surveillance: Long-term use (12 months)
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 3,000 人开始时间: 2013年12月3日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Post-marketing surveillance
排除标准
- •(1) Patients with a history of hypersensitivity to ingredients of ECARD LD&HD combination tablets, thiazides, or their analogues (e.g. sulphonamide derivatives such as chlortalidone)
- •(2) Patients with anuria or patients under hemodialysis
- •(3) Patients with acute renal failure
- •(4) Patients with noticeably decreased Na and K levels in body fluids
- •(5) Pregnant women or women planning to become pregnant
研究者
相似试验
未知
Unknown
Zacras Combination Tablets LD & HD specified drug-use survey Long-term use surveyHypertensionJPRN-jRCT1080222541TAKEDA PHARMACEUTICAL COMPANY LTD.1,090
未知
Unknown
nisia Combination Tablets LD, HD Special Drug Use Surveillance Hypertension: Long-Term UseHypertensionJPRN-jRCT1080222340TAKEDA PHARMACEUTICAL COMPANY LTD.3,000
未知
Unknown
iovel Combination Tablets special drug use surveillance Long-term use in patients with type 2 diabetes mellitusJPRN-jRCT1080222253TAKEDA PHARMACEUTICAL COMPANY LTD.3,000
未知
Unknown
Metact Combination Tablets special drug use surveillance Survey on long-term use for type 2 diabetes mellitusJPRN-jRCT1080222318TAKEDA PHARMACEUTICAL COMPANY LTD.1,000
未知
Unknown
Sonias Combination Tablets LD special drug use surveillance Survey on Type 2 diabetes mellitus: Insufficient treatment response to PioglitazoneType 2 diabetes mellitusJPRN-jRCT1080222395TAKEDA PHARMACEUTICAL COMPANY LTD.210